Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Ras Gene02:38

The Ras Gene

7.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.1K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

9.8K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.8K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026
Same author

RAC1 regulates Sonic Hedgehog-medulloblastoma growth via GLI-mediated transcription.

Neuro-oncology·2026
Same author

Targeting β-catenin: PROTACs and precision degraders for Wnt-driven cancers.

Frontiers in oncology·2026
Same author

Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study.

JAMA neurology·2026
Same author

Wnt signaling is modulated by the buffer-like properties of cadherins.

Molecular biology of the cell·2026
Same author

Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations.

Nature communications·2026

Related Experiment Video

Updated: Jan 18, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

1.0K

RAC1 Regulates Shh-Medulloblastoma Growth via GLI-Mediated Transcription.

Nitish Jangde, Mi Hye Lee, Luz Ruiz

    Biorxiv : the Preprint Server for Biology
    |June 6, 2025
    PubMed
    Summary

    We identified RAC1 as a key driver in Shh-medulloblastoma (MB) progression. Inhibiting RAC1 with the drug candidate GYS32661 reduced tumor growth and improved survival in preclinical models, offering a potential new therapy for MB.

    More Related Videos

    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
    05:10

    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

    Published on: October 3, 2010

    12.6K
    Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
    06:32

    Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

    Published on: September 1, 2010

    16.8K

    Related Experiment Videos

    Last Updated: Jan 18, 2026

    Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
    07:26

    Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

    Published on: January 31, 2025

    1.0K
    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
    05:10

    Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

    Published on: October 3, 2010

    12.6K
    Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
    06:32

    Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

    Published on: September 1, 2010

    16.8K

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Medulloblastoma (MB) is the most common malignant pediatric brain tumor.
    • Current therapies are insufficient for treating MB proliferation, migration, and metastasis.
    • The small GTPase RAC1 regulates actin dynamics, proliferation, and migration in various cancers but remains uncharacterized in MB.

    Purpose of the Study:

    • To investigate the role of RAC1 in Shh-MB.
    • To identify RAC1 as a potential therapeutic target for MB.

    Main Methods:

    • Assessed RAC1 levels in MB tissue.
    • Depleted RAC1 in Shh-MB cells to evaluate proliferation and migration.
    • Investigated RAC1's mechanism of action on Shh pathway transcription factors.
    • Tested the efficacy of the RAC1 inhibitor GYS32661 in an orthotopic Shh-MB mouse model.

    Main Results:

    • RAC1 levels are elevated in MB tissue compared to normal cerebellum.
    • RAC1 depletion significantly reduced Shh-MB cell proliferation and migration in vitro.
    • RAC1 directly binds to the GLI1 promoter, regulating Shh pathway transcription.
    • The brain-penetrant RAC1 inhibitor GYS32661 reduced MB tumor growth and increased survival in mice.

    Conclusions:

    • RAC1 is a critical regulator of Shh-MB progression.
    • Targeting RAC1 with GYS32661 shows therapeutic potential for both pediatric and adult MB.
    • RAC1 represents a novel, druggable target for Shh-dependent medulloblastoma.